Mechanisms for Activation of Beige Adipose Tissue in Humans; Supplement
Mechanisms for Activation of Beige Adipose Tissue in Humans; Supplement
批准号:
10630687
负责人:
Philip A Kern
金额:
$47.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-12-01 至 2025-11-30
关键词:
Academic Medical CentersAddressAdipose tissueAdultAmericasAreaAutoantibodiesAutoimmunityBeta CellBody mass indexC-PeptideCOVID-19COVID-19 impactCOVID-19 pandemicCOVID-19 severityCaringChildChildhoodClinicalClinical DataCodeCommunitiesDataData AnalysesData SetData SourcesDatabasesDevelopmentDiabetes MellitusDiabetic KetoacidosisDiagnosisElectronic Health RecordEndocrinologistEpidemiologistEpidemiologyEthnic OriginGlucocorticoidsGlycosylated hemoglobin AHealthHealthcareHigh PrevalenceHumanIncidenceIndividualInfectionInflammationInflammatoryInpatientsInsulin ResistanceInsulin-Dependent Diabetes MellitusKentuckyLaboratoriesLinkLungMedicaidNon-Insulin-Dependent Diabetes MellitusObesityOutpatientsPatientsPersonsPharmaceutical PreparationsPopulationProcessRaceRegistriesReportingResourcesRetrospective cohortRiskRuralSARS-CoV-2 infectionSeveritiesSeverity of illnessTest ResultUnited StatesUniversitiesVaccinationVaccinesVital Statisticsautoimmune pathogenesisbeneficiaryclinically relevantcoronavirus diseasedesigndiabetogenichealth disparityhigh riskimprovedmarginalized populationpost SARS-CoV-2 infectionresponsesevere COVID-19sociodemographicssocioeconomic disadvantagestudy populationtrendvaccine acceptance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
This proposal is a supplement to “Mechanisms for Activation of Beige Adipose Tissue in Humans”, R01
DK124626 in response to NOT-DK-22-017. The supplement is titled: “Impact of COVID-19 on diabetes
incidence and severity in the United States and Kentucky”.
There is mounting evidence that COVID-19 is associated with increased risk of incident diabetes. This
supplement assembles a team of Endocrinologists, Pulmonary intensivists, Informaticians, Epidemiologists and
Statisticians who will perform a detailed analysis of linked comprehensive data sets to identify key factors (and
putative mechanisms) that relate COVID-19 infection to incident diabetes. In the proposed project, the team
will explore the COVID and incident diabetes relationship among adults and children using three distinct data
sources: 1) a large, nationwide database of commercially insured individuals (MarketScan), 2) Kentucky state
Medicaid claims data, and 3) detailed clinical data from the University of Kentucky HealthCare (UKHC)
electronic health record (EHR). Our overall hypothesis is that new onset diabetes is greater in subjects with the
most severe COVID infections and in areas of Kentucky with the health disparities. To address these
hypotheses, we propose the following Specific Aims, 1) to compare population-level trends in the incidence
and severity of new onset diabetes during the COVID-19 pandemic (2020-2021) to historical data (2018-2019)
in three distinct study populations, and 2) to examine the association between COVID infection and incident
diabetes at the individual level using a matched, retrospective cohort design. We will also examine factors that
modify this association, including severity of diabetes, diabetes type, sociodemographics (age, race/ethnicity,
region), BMI, severity of COVID infection, vaccination status, timing of diabetes onset following COVID-19, and
overall health from diagnosis codes, lab values, medications and clinical notes. In summary, this study will
examine the relationship between COVID-19 and incident diabetes in very different populations, including rural
Kentucky, which has high health disparities. In addition, we will examine the effects of prior vaccination, which
may lessen the severity of disease and decrease diabetes incidence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mirabegron and tadalafil effectiveness for treatment of prediabetes
-
批准号:10363388
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2021
-
负责人:Philip A Kern
-
依托单位:
Mirabegron and tadalafil effectiveness for treatment of prediabetes
-
批准号:10532229
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2021
-
负责人:Philip A Kern
-
依托单位:
Mechanisms for activation of beige adipose tissue in humans
-
批准号:10531210
-
项目类别:
-
资助金额:$60.91万
-
财政年份:2020
-
负责人:Philip A Kern
-
依托单位:
Mechanisms for activation of beige adipose tissue in humans
-
批准号:10308496
-
项目类别:
-
资助金额:$60.91万
-
财政年份:2020
-
负责人:Philip A Kern
-
依托单位:
The activation of brown and beige fat and role in insulin sensitivity
-
批准号:9241565
-
项目类别:
-
资助金额:$54.41万
-
财政年份:2016
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:10459638
-
项目类别:
-
资助金额:$331.99万
-
财政年份:2016
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:10185144
-
项目类别:
-
资助金额:$120.0万
-
财政年份:2016
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:10681386
-
项目类别:
-
资助金额:$331.99万
-
财政年份:2016
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:9314011
-
项目类别:
-
资助金额:$364.53万
-
财政年份:2016
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:10733214
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2016
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:10405236
-
项目类别:
-
资助金额:$331.99万
-
财政年份:2016
-
负责人:Philip A Kern
-
依托单位:
Cold Induced Changed in Human Subcutaneous White Adipose
-
批准号:9321959
-
项目类别:
-
资助金额:$50.89万
-
财政年份:2015
-
负责人:Philip A Kern
-
依托单位:
Cold Induced Changed in Human Subcutaneous White Adipose
-
批准号:9008664
-
项目类别:
-
资助金额:$51.89万
-
财政年份:2015
-
负责人:Philip A Kern
-
依托单位:
Dietary fat, lipoproteins, and lipopolysaccharide: role in insulin resistance
-
批准号:8835108
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2014
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:8269774
-
项目类别:
-
资助金额:$335.32万
-
财政年份:2011
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:8866250
-
项目类别:
-
资助金额:$339.48万
-
财政年份:2011
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:8262003
-
项目类别:
-
资助金额:$16.06万
-
财政年份:2011
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:8269769
-
项目类别:
-
资助金额:$15.01万
-
财政年份:2011
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:8637113
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2011
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:8637115
-
项目类别:
-
资助金额:$49.5万
-
财政年份:2011
-
负责人:Philip A Kern
-
依托单位:
海外基金